| Ytd | 2.15% | |
| 1y | 23.22% |
| Open | 319.19 | Prev Close | 318.87 | Low | 317.50 | High | 318.90 | Mkt Cap | 12.51B |
| Vol | 994.50K | Avg Vol | 335.47K | EPS | 4.08 | P/E | 77.84 | Forward P/E | 51.80 |
| Beta | 0.70 | Short Ratio | 6.28 | Inst. Own | 88.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 321.42 | 200-d Avg | 325.69 | 1yr Est | 361.83 |
PEN's portfolio expansion and international growth support momentum, while rising costs, FX exposure
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Pen
Connor Clark and Lunn Investment Management Ltd. purchased a new position in shares of Penumbra, Inc
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Pen
Incuvate, LLC today announced that it has filed a patent-infringement lawsuit against Penumbra, Inc.
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Pen
Penumbra (NYSE:PEN) reported quarterly earnings of $0.88 per share which missed the analyst consensu
ALAMEDA, Calif., July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading throm
Bank of Nova Scotia boosted its stake in Penumbra, Inc. (NYSE: PEN) by 14,837.9% during the first qu
California Public Employees Retirement System lifted its stake in shares of Penumbra, Inc. (NYSE: PE
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care PR Newswire
First and only CAVT device for stroke demonstrated high revascularization rates, short procedure tim
Bank of New York Mellon Corp decreased its stake in shares of Penumbra, Inc. (NYSE: PEN) by 0.9% dur
When investors think of the health care sector, most imagine the stability of pharmaceutical giants
Investors interested in stocks from the Medical - Instruments sector have probably already heard of
Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation o
ALAMEDA, Calif., July 7, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thromb
Evercore ISI Group analyst Vijay Kumar maintains Penumbra (NYSE:PEN) with a Outperform and lowers
Investors looking for stocks in the Medical - Instruments sector might want to consider either Globu
PEN gains CE Mark in Europe for THUNDERBOLT, expanding stroke treatment access and advancing its glo
The THUNDERBOLT TM Computer Assisted Vacuum Thrombectomy (CAVT TM ) technology introduces modulated
THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — e
Investors interested in stocks from the Medical - Instruments sector have probably already heard of
Penumbra (PEN) reported earnings 30 days ago. What's next for the stock?
Consolidation wave creates opportunities for patient investors. 8 sectors leading now are health, se
U.S. stocks rallied near record territory on Thursday as blowout earnings from major Wall Street fir
Penumbra (PEN) climbs on strong Q4 results and acquisition agreement with Boston Scientific (BSX), d
Wall Street traded timidly on Tuesday despite another benign inflation report that reinforced expect
Expedia, SanDisk, and Penumbra led last week's large-cap gainers, with strong earnings and raise
Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investo
Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings